Walpar Nutrition

Why is Walpar Nutritions Ltd falling/rising?

As of 28-Jun, Walpar Nutritions Ltd's stock price is rising to 25.25, reflecting a 3.7% increase and outperforming the sector. Increased investor participation and short-term positive momentum suggest a potential recovery phase despite a year-to-date decline of 47.23%.

As of 28-Jun, Walpar Nutritions Ltd's stock price is rising, currently at 25.25, reflecting a change of 0.9 or 3.7% increase. This upward movement is notable as it outperformed the sector by 2.97% today. Additionally, there has been a significant increase in investor participation, with delivery volume rising by 51.52% compared to the 5-day average, indicating growing interest in the stock. <BR><BR>Despite a challenging year-to-date performance, where the stock is down 47.23%, the current rise can be attributed to short-term positive momentum and increased trading activity. The stock is currently higher than its 5-day moving average, although it remains below the longer-term moving averages, suggesting a potential recovery phase. Overall, the combination of today's performance and rising investor engagement contributes to the stock's current upward trend.

Which are the latest news on Walpar Nutrition?

What does Walpar Nutrition do?

Walpar Nutritions Ltd is a micro-cap company in the FMCG sector, originally established in 2009, with no recent sales or profit data reported. It has a market cap of INR 22 Cr, a P/E ratio of 9.00, and a debt-equity ratio of 0.63.

Overview:<BR>Walpar Nutritions Ltd operates in the Fast-Moving Consumer Goods (FMCG) sector and is categorized as a micro-cap company.<BR><BR>History:<BR>Walpar Nutritions Ltd was originally formed as a Partnership Firm named "M/s Walpar Healthcare" in 2009. The partnership underwent several changes in its constitution on March 9, 2015, August 15, 2017, and June 12, 2020. There is no recent sales or profit data reported.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 22 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 9.00<BR>Industry P/E: 45<BR>Dividend Yield: 0.00%<BR>Debt-Equity: 0.63<BR>Return on Equity (ROE): 13.07%<BR>Price-to-Book: 1.22<BR><BR>Contact Details:<BR>Registrar Address: Not available<BR>Phone: N/A<BR>Email: N/A<BR>Website: N/A

How big is Walpar Nutrition?

As of 10th June, Walpar Nutrition Ltd has a market capitalization of 22.00 Cr, classifying it as a Micro Cap company, with Shareholder's Funds of 16.56 Cr and Total Assets of 47.39 Cr reported as of March 2025. There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.

As of 10th June, <BR><BR>Market Cap: Walpar Nutritions Ltd has a market capitalization of 22.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The latest reporting period is March 2025, with Shareholder's Funds amounting to 16.56 Cr and Total Assets valued at 47.39 Cr.

Who are in the management team of Walpar Nutrition?

The management team of Walpar Nutrition includes Chairman & Managing Director Kalpesh Pravinchandra Ladhawala, along with several Executive Directors and Independent Directors, overseeing the company's operations and strategic direction. Key members include Tanmaykumar Ashwinbhai Shah, Sejal Ladhawala, and Megha Shah, among others.

The management team of Walpar Nutrition includes the following members:<BR><BR>1. **Kalpesh Pravinchandra Ladhawala** - Chairman & Managing Director<BR>2. **Tanmaykumar Ashwinbhai Shah** - Whole-time Director<BR>3. **Sejal Ladhawala** - Executive Director<BR>4. **Abhishekkumar Dineshkumar Patel** - Executive Director<BR>5. **Fenil Prakashkumar Sha** - Executive Director<BR>6. **Jigneshkumar Dineshkumar Modi** - Executive Director<BR>7. **Krunal Jashubhai Patel** - Executive Director<BR>8. **Nidhi YogeshKumar Shah** - Executive Director<BR>9. **Divyanshu Subhashchandra Raval** - Executive Director<BR>10. **Jayshukh Ramjibhai Detroja** - Additional Non-Executive Director & Independent Director<BR>11. **Rupesh Himatla Shah** - Additional Non-Executive Director & Independent Director<BR>12. **Tapan Natverlal Patel** - Additional Non-Executive Director & Independent Director<BR>13. **Nehalkumar Jasvantlal Shah** - Additional Non-Executive Director & Independent Director<BR>14. **Priyanka Shah** - Company Secretary<BR>15. **Megha Shah** - Independent Director<BR><BR>This team is responsible for overseeing the operations and strategic direction of the company.

Who are the peers of the Walpar Nutrition?

Walpar Nutrition's peers include Tapi Fruit, Jay Kailash, Lake Shore, Sonalis Consumer, Hipolin, Novateor Research, KMG Milk Food, Indong Tea Co, and Chordia Food. In terms of management risk, Walpar Nutrition has a Good rating, while its 1-year return is -54.54%, the lowest among its peers.

Peers: The peers of Walpar Nutrition are Tapi Fruit, Jay Kailash, Lake Shore, Sonalis Consumer, Hipolin, Novateor Resear., KMG Milk Food, Indong Tea Co, and Chordia Food.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sonalis Consumer, while Good management risk is found at Walpar Nutrition. Below Average management risk is noted for Tapi Fruit, Jay Kailash, Hipolin, Novateor Resear., and Indong Tea Co, and the rest. Lake Shore, KMG Milk Food, and BKV Industries do not qualify for management risk assessment. In terms of Growth, Sonalis Consumer shows Excellent growth, Walpar Nutrition has Good growth, and Average growth is seen at Jay Kailash, with the rest falling into Below Average. For Capital Structure, Good is noted for Walpar Nutrition and Sonalis Consumer, while Below Average is observed for Tapi Fruit, Jay Kailash, Hipolin, Novateor Resear., Indong Tea Co, Chordia Food, and the rest do not qualify.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Jay Kailash at 0.00%, while the peer with the lowest is Walpar Nutrition at -54.54%. Walpar Nutrition's 1-year return is significantly lower than that of its peers. Additionally, all peers except Jay Kailash and others have a negative six-month return.

Is Walpar Nutrition overvalued or undervalued?

As of November 17, 2025, Walpar Nutrition is considered very attractive and undervalued with a PE ratio of 24.64 and an EV to EBITDA of 14.13, making it a more appealing investment compared to peers like Hindustan Unilever and Nestle India, despite a year-to-date return of -12.18% against the Sensex's 10.02%.

As of 17 November 2025, the valuation grade for Walpar Nutrition has moved from attractive to very attractive, indicating a strong positive shift in its valuation outlook. The company is currently assessed as undervalued. Key ratios include a PE ratio of 24.64, an EV to EBITDA of 14.13, and a PEG ratio of 0.47, which suggests that the stock is priced favorably relative to its growth prospects.<BR><BR>In comparison to its peers, Walpar Nutrition stands out with its lower valuation metrics; for instance, Hindustan Unilever has a PE ratio of 53.89 and an EV to EBITDA of 38.18, while Nestle India shows a PE of 81.88. This positions Walpar Nutrition as a more attractive investment opportunity within the FMCG sector. Despite recent underperformance against the Sensex, with a year-to-date return of -12.18% compared to the Sensex's 10.02%, the company's strong fundamentals and favorable valuation ratios suggest potential for future growth.

How has been the historical performance of Walpar Nutrition?

Walpar Nutrition has demonstrated significant growth from Mar'21 to Mar'25, with net sales increasing from 6.07 Cr to 71.76 Cr, and profit after tax rising from 0.15 Cr to 2.80 Cr, reflecting enhanced profitability and shareholder value. Total assets and liabilities have also grown proportionally, indicating a strong financial performance across various metrics.

Answer:<BR>The historical performance of Walpar Nutrition shows significant growth in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Walpar Nutrition's net sales have increased from 6.07 Cr in Mar'21 to 71.76 Cr in Mar'25, demonstrating a robust upward trend. The total operating income followed a similar trajectory, rising from 6.07 Cr in Mar'21 to 71.76 Cr in Mar'25. Raw material costs have also escalated, from 4.56 Cr in Mar'21 to 56.89 Cr in Mar'25, reflecting the company's expanding operations. Operating profit (PBDIT) has improved from 0.46 Cr in Mar'21 to 5.99 Cr in Mar'25, while profit before tax has surged from 0.16 Cr to 3.88 Cr during the same period. Profit after tax has risen from 0.15 Cr in Mar'21 to 2.80 Cr in Mar'25, indicating enhanced profitability. The earnings per share (EPS) have increased from 0.45 in Mar'21 to 2.47 in Mar'25, showcasing improved shareholder value. Total assets have grown from 17.97 Cr in Mar'21 to 47.39 Cr in Mar'25, while total liabilities increased from 17.97 Cr to 47.39 Cr, indicating a proportional growth in the company's financial structure. The cash flow from operating activities has remained positive, with a net cash inflow of 1.00 Cr in Mar'25 compared to previous years. Overall, Walpar Nutrition has shown a strong performance trajectory across various financial metrics over the years.

Who are the top shareholders of the Walpar Nutrition?

The top shareholders of Walpar Nutrition include Kalpesh Pravinchandra Ladhawala with 18.36%, individual investors with 22.58%, and Xtended Business Reporting Limited as the largest public shareholder at 2.22%. There are no mutual funds or foreign institutional investors involved.

The top shareholders of Walpar Nutrition are primarily the promoters, with Kalpesh Pravinchandra Ladhawala holding the largest share at 18.36%. In addition to him, individual investors collectively own 22.58% of the company. The highest public shareholder is Xtended Business Reporting Limited, which holds 2.22%. There are currently no mutual funds or foreign institutional investors holding shares in the company.

What is the technical trend for Walpar Nutrition?

As of June 4, 2025, Walpar Nutrition's trend is neutral with mixed signals, showing a shift from mildly bearish to sideways, as indicated by conflicting MACD readings and weak overall trend strength.

As of 4 June 2025, the technical trend for Walpar Nutrition has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across various indicators. The weekly MACD is mildly bullish, while the monthly MACD is mildly bearish, indicating conflicting momentum. The RSI shows no signal on both weekly and monthly time frames, suggesting indecision. Daily moving averages are mildly bearish, contrasting with the weekly KST and Dow Theory, both of which are mildly bullish. The Bollinger Bands indicate a bullish trend on the weekly and a sideways trend on the monthly. Overall, the strength of the trend is weak, reflecting the sideways movement in price action and the lack of strong directional signals.

When is the next results date for Walpar Nutrition?

No Upcoming Board Meetings

What is the bonus history of the Walpar Nutrition?

Walpar Nutrition has announced a 1:1 bonus issue, with an ex-date and record date of August 14, 2024. Shareholders will receive one additional share for each share they own on that date.

Walpar Nutrition has announced a bonus issue with a ratio of 1:1. The ex-date for this bonus is set for August 14, 2024. This means that shareholders will receive one additional share for every share they currently own on that date. The record date for this bonus is also August 14, 2024. If you have any more questions about the company or its financial activities, feel free to ask!

Has Walpar Nutrition declared dividend?

No Dividend History Available